Blood tests could revolutionize how doctors detect and monitor lung cancer recurrence
NCT ID NCT05665504
Summary
This study aims to improve lung cancer care by testing whether specific biomarkers in blood and tissue can better diagnose lung nodules, identify patients at high risk of cancer returning after surgery, and detect late recurrence. Researchers will follow 250 adults with suspicious lung nodules who are scheduled for surgery or radiation treatment at Moffitt Cancer Center. The study focuses on observational testing rather than providing new treatments, with the goal of developing better tools for diagnosis and long-term monitoring.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF LUNG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.